Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013923 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
A Phase 2 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00013923 is a Phase 2 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 40 participants.
The verdict
NCT00013923, a Phase 2 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.
Interventions
- DRUG Nutritional Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00013923
The ClinicalTrials.gov registry entry for NCT00013923 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nutritional Supplement is the first listed.
NCT00013923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00013923 about?
NCT00013923 is a clinical study titled "Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease". The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.
What is the current status of trial NCT00013923?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00013923?
The interventions under investigation include: Nutritional Supplement (DRUG).
Who is sponsoring clinical trial NCT00013923?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.